EFFICACY OF TRANEXAMIC ACID IN THE PREVENTION OF POSTPARTUM HEMORRHAGE: A NARRATIVE LITERATURE REVIEW
DOI:
https://doi.org/10.36557/2674-9432.2026v5n3p512-521Palavras-chave:
Postpartum Hemorrhage; Tranexamic Acid; Prevention; Maternal HealthResumo
Postpartum hemorrhage (PPH) remains one of the leading causes of maternal morbidity and mortality worldwide, requiring effective strategies for prevention, early recognition, and timely management. In this context, tranexamic acid has been investigated as a pharmacological intervention capable of reducing obstetric blood loss through inhibition of fibrinolysis. This study aimed to analyze the efficacy of tranexamic acid in the prevention of postpartum hemorrhage based on contemporary scientific literature. This is a narrative literature review conducted through searches in databases such as PubMed, Scopus, and the Virtual Health Library, using descriptors related to tranexamic acid, postpartum hemorrhage, and prevention. Studies published between 2018 and 2026 were prioritized, including randomized clinical trials, systematic reviews, international recommendations, and clinical guidelines. Findings indicate that tranexamic acid may reduce blood loss during childbirth, particularly in cesarean deliveries, although its effectiveness in reducing major clinical outcomes such as transfusion and maternal mortality remains inconsistent. In vaginal deliveries, recent evidence suggests limited benefit when used prophylactically alongside active management of the third stage of labor. It is concluded that tranexamic acid represents a promising strategy; however, its preventive use should be individualized, integrated into institutional protocols, and supported by careful risk assessment.
Downloads
Referências
ACOG. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstetrics & Gynecology, v. 130, n. 4, p. e168–e186, 2017. Available at: https://doi.org/10.1097/AOG.0000000000002351. Accessed on: Mar 9, 2026.
BRENNER, A. et al. Tranexamic acid for post-partum haemorrhage: what, who and when. Best Practice & Research Clinical Obstetrics & Gynaecology, v. 61, p. 66–74, 2019. Available at: https://doi.org/10.1016/j.bpobgyn.2019.04.001. Accessed on: Mar 9, 2026.
ESCOBAR, M. F. et al. FIGO recommendations on the management of postpartum hemorrhage 2022. International Journal of Gynecology & Obstetrics, v. 157, Suppl. 1, p. 3–50, 2022. DOI: 10.1002/ijgo.14116. Available at: https://doi.org/10.1002/ijgo.14116. Accessed on: Mar 9, 2026.
PACHECO, L. D. et al. Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery. The New England Journal of Medicine, v. 388, p. 1365–1375, 2023. DOI: 10.1056/NEJMoa2207419. Available at: https://doi.org/10.1056/NEJMoa2207419. Accessed on: Mar 9, 2026.
ROHWER, C. et al. Tranexamic acid for preventing postpartum haemorrhage after caesarean section. Cochrane Database of Systematic Reviews, n. 11, CD016278, 2024. DOI: 10.1002/14651858.CD016278. Available at: https://doi.org/10.1002/14651858.CD016278. Accessed on: Mar 11, 2026.
ROHWER, C. et al. Tranexamic acid for preventing postpartum haemorrhage after vaginal birth. Cochrane Database of Systematic Reviews, n. 1, CD007872, 2025. DOI: 10.1002/14651858.CD007872.pub4. Available at: https://doi.org/10.1002/14651858.CD007872.pub4. Accessed on: Mar 7, 2026.
SENTILHES, L. et al. Tranexamic Acid for the Prevention of Blood Loss after Vaginal Delivery. The New England Journal of Medicine, v. 379, p. 731–742, 2018. DOI: 10.1056/NEJMoa1800942. Available at: https://doi.org/10.1056/NEJMoa1800942. Accessed on: Mar 9, 2026.
SENTILHES, L. et al. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery. The New England Journal of Medicine, v. 384, p. 1623–1634, 2021. DOI: 10.1056/NEJMoa2028788. Available at: https://doi.org/10.1056/NEJMoa2028788. Accessed on: Mar 5, 2026.
WOMAN TRIAL COLLABORATORS. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. The Lancet, v. 389, n. 10084, p. 2105–2116, 2017. DOI: 10.1016/S0140-6736(17)30638-4. Available at: https://doi.org/10.1016/S0140-6736(17)30638-4. Accessed on: Mar 12, 2026.
WORLD HEALTH ORGANIZATION. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage. Geneva: World Health Organization, 2017.
Available at: https://www.who.int/publications/i/item/WHO-RHR-17.21. Accessed on: Mar 12, 2026.
WORLD HEALTH ORGANIZATION. Postpartum haemorrhage. Geneva: World Health Organization, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/postpartum-haemorrhage. Accessed on: Mar 12, 2026.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2026 Kellen de Pícoli Alexandre, Rodolfo de Oliveira Medeiros, Cristiano Machado Galhardi, Melissa Antunes, Marília Bedani de Oliveira, Felipe Colatto Alves, Ana Clara Moreira Seabra, Hacise Colatto, Laysa Ohana Mada, Felipe Ravazzi Guzzo, Maria Victoria Santos Kloster, Eduardo Antônio Ferro Faria, Izabela Manfio Rorato
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
